Skip to content

A study to compare the outcome of Umbilical Cord Serum as an adjuvant to Standard of Care alone in view of vision improvement,Dry eyes, healing in patients of Corneal disease.

"To determine therapeutic role of topical Umblical Cord Serum as an adjuvant therapy in improving various clinical parameters(dry eyes,healing/epithelialization,vision improvement and OSDI score)in patients of acute corneal insult,Persistent Epithelial Defects and non-infectiouskeratitis in comparison to Standard Of Care alone"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046978
Enrollment
200
Registered
2022-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

Intervention1: Umblical Cord Serum: Umblical Cord Serum as an adjuvant therapy with Standard Of Care in improving various clinical parameters(dry eyes,healing/epithelialization,vision improvement and

Sponsors

Multi-Disciplinary Research Unit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Ambulatory patients of either gender ï?³18 years at the time of screening after informed consent. 2 In acute corneal insult, PED and keratitis of duration less than 2 weeks.

Exclusion criteria

Exclusion criteria: 1) Acute ocular injury requiring surgery, ocular perforation, infections, acute chemical injuries requiring interventions and patients with poor visual prognosis, bedridden, debilitated or malignant patients. 2). Patients suffering from advance ocular diseases like advance glaucoma or advance retinal diseases 3). Patients who are not willing for complete workup or written consent. 4). Patients with active infective diseases like TB, herpes zoster etc. 5). Patients who are HIV, HBsAg, HCV test positive 6). Evidence of active infection in concern eye or in other eye. 7). Patients with no allergic reaction. 8). Presence of uncontrolled systolic blood pressure ï?³160mmHg or uncontrolled diastolic blood pressure ï?³ 100mgHg. 9). Inability to obtain fundus photographs or Fluorescein angiograms of sufficient quality 10). Female subjects who are pregnant, breast feeding planning to be pregnant during the study

Design outcomes

Primary

MeasureTime frame
Improvement in various clinical parameters dry eyes, healing/epithelialization, vision improvement and OSDI scoreTimepoint: 6-8 weeks

Secondary

MeasureTime frame
Improvement in various clinical parameters dry eyes, healing/epithelialization, vision improvement and OSDI scoreTimepoint: 6 months

Countries

India

Contacts

Public ContactDharamveer S Choudhary

SMS Medical College ,Jaipur

drdschoudhary@gmail.com09252032662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026